Entry
Name
Human papillomavirus infection - Carlito syrichta (Philippine tarsier)
Description
Human papillomavirus (HPV) is a non-enveloped, double-stranded DNA virus. HPV infect mucoal and cutaneous epithelium resulting in several types of pathologies, most notably, cervical cancer. All types of HPV share a common genomic structure and encode eight proteins: E1, E2, E4, E5, E6, and E7 (early) and L1 and L2 (late). It has been demonstrated that E1 and E2 are involved in viral transcription and replication. The functions of the E4 protein is not yet fully understood. E5, E6, and E7 act as oncoproteins. E5 inhibits the V-ATPase, prolonging EGFR signaling and thereby promoting cell proliferation. The expression of E6 and E7 not only inhibits the tumor suppressors p53 and Rb, but also alters additional signalling pathways. Among these pathways, PI3K/Akt signalling cascade plays a very important role in HPV-induced carcinogenesis. The L1 and L2 proteins form icosahedral capsids for progeny virion generation.
Class
Human Diseases; Infectious disease: viral
BRITE hierarchy
Pathway map
Ortholog table
Organism
Carlito syrichta (Philippine tarsier) [GN:
csyr ]
Gene
103250886 segment polarity protein dishevelled homolog DVL-1-like [KO:K02353 ]
103263236 DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X1 [KO:K02353 ]
103273282 DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353 ]
103275489 MAGI1; membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X7 [KO:K05631 ]
103272302 COL6A6; LOW QUALITY PROTEIN: collagen alpha-6(VI) chain [KO:K06238 ]
103250566 TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158 ]
103269228 TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein isoform X2 [KO:K03171 ]
103273211 FASLG; tumor necrosis factor ligand superfamily member 6 isoform X1 [KO:K04389 ]
103273943 FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390 ]
103259736 SLC9A3R1; Na(+)/H(+) exchange regulatory cofactor NHE-RF1 [KO:K13365 ]
103261468 serine/threonine-protein phosphatase 2A catalytic subunit beta isoform isoform X2 [KO:K04382 ] [EC:3.1.3.16 ]
103268313 PPP2CA; serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform [KO:K04382 ] [EC:3.1.3.16 ]
103256338 PPP2R1B; serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform X3 [KO:K03456 ]
103258353 PPP2R1A; serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform isoform X1 [KO:K03456 ]
103254381 serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform-like [KO:K04354 ]
103252361 serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1 [KO:K04354 ]
103263175 PPP2R2A; serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform [KO:K04354 ]
103262435 serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform-like [KO:K04354 ]
103273997 PPP2R3C; serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma isoform X1 [KO:K11583 ]
103259194 PPP2R3A; serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform X1 [KO:K11583 ]
103266449 PPP2R5C; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform X2 [KO:K11584 ]
103275607 PPP2R5B; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform [KO:K11584 ]
103276158 PPP2R5A; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform [KO:K11584 ]
103268163 PPP2R5E; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform isoform X1 [KO:K11584 ]
103268546 PPP2R5D; serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform isoform X1 [KO:K11584 ]
103251553 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922 ] [EC:2.7.1.153 ]
103266233 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
103276054 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X2 [KO:K00922 ] [EC:2.7.1.153 ]
103262537 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649 ]
103272136 PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2 [KO:K02649 ]
103264812 CDKN1B; LOW QUALITY PROTEIN: cyclin-dependent kinase inhibitor 1B [KO:K06624 ]
103262949 VEGFA; vascular endothelial growth factor A isoform X2 [KO:K05448 ]
103274648 NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580 ]
103251756 CHD4; chromodomain-helicase-DNA-binding protein 4 [KO:K11643 ] [EC:5.6.2.-]
103251393 class I histocompatibility antigen, Gogo-B*0101 alpha chain-like [KO:K06751 ]
103273534 HLA class I histocompatibility antigen, B-15 alpha chain-like [KO:K06751 ]
103268467 patr class I histocompatibility antigen, B-2 alpha chain-like isoform X1 [KO:K06751 ]
103271436 HLA class I histocompatibility antigen, A-11 alpha chain-like [KO:K06751 ]
103273536 HLA class I histocompatibility antigen, B-15 alpha chain-like [KO:K06751 ]
103276998 HLA class I histocompatibility antigen, B-37 alpha chain-like [KO:K06751 ]
103277080 HLA class I histocompatibility antigen, A-23 alpha chain-like [KO:K06751 ]
103251038 BCAP31; B-cell receptor-associated protein 31 isoform X1 [KO:K14009 ]
103261161 ATP6V1B1; V-type proton ATPase subunit B, kidney isoform [KO:K02147 ]
103276577 ATP6V1B2; V-type proton ATPase subunit B, brain isoform [KO:K02147 ]
103254908 ATP6V1C1; V-type proton ATPase subunit C 1 isoform X1 [KO:K02148 ]
103267979 ATP6V1C2; V-type proton ATPase subunit C 2 isoform X1 [KO:K02148 ]
103270146 ATP6V1G2; V-type proton ATPase subunit G 2 isoform X1 [KO:K02152 ]
103264706 ATP6V1G3; LOW QUALITY PROTEIN: V-type proton ATPase subunit G 3 [KO:K02152 ]
103250233 ATP6V0A1; V-type proton ATPase 116 kDa subunit a isoform X3 [KO:K02154 ]
103251303 ATP6V0C; V-type proton ATPase 16 kDa proteolipid subunit [KO:K02155 ]
103260759 ATP6V0B; V-type proton ATPase 21 kDa proteolipid subunit isoform X2 [KO:K03661 ]
103267942 EGF; LOW QUALITY PROTEIN: pro-epidermal growth factor [KO:K04357 ]
103275922 GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364 ]
103255823 guanine nucleotide-binding protein G(s) subunit alpha isoform X1 [KO:K04632 ]
103252293 CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870 ]
103249547 CREB3L3; LOW QUALITY PROTEIN: cyclic AMP-responsive element-binding protein 3-like protein 3 [KO:K09048 ]
103252136 CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 [KO:K09048 ]
103263755 CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048 ]
103265465 CREB3; cyclic AMP-responsive element-binding protein 3 isoform X1 [KO:K09048 ]
103257302 CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048 ]
103273492 CREB5; cyclic AMP-responsive element-binding protein 5 isoform X2 [KO:K09047 ]
103256404 STAT1; signal transducer and activator of transcription 1-alpha/beta isoform X1 [KO:K11220 ]
103258295 LOW QUALITY PROTEIN: signal transducer and activator of transcription 2-like [KO:K11221 ]
103271654 EIF2AK2; interferon-induced, double-stranded RNA-activated protein kinase isoform X1 [KO:K16195 ] [EC:2.7.11.1 ]
103277220 LOW QUALITY PROTEIN: interferon-induced GTP-binding protein Mx1-like [KO:K14754 ]
103257989 RBPJ; recombining binding protein suppressor of hairless isoform X2 [KO:K06053 ]
103259852 RBPJL; recombining binding protein suppressor of hairless-like protein [KO:K06053 ]
103264995 HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X2 [KO:K09091 ]
103256519 HEYL; hairy/enhancer-of-split related with YRPW motif-like protein isoform X1 [KO:K09091 ]
Compound
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference
Authors
Moody CA, Laimins LA
Title
Human papillomavirus oncoproteins: pathways to transformation.
Journal
Reference
Authors
Chen J
Title
Signaling pathways in HPV-associated cancers and therapeutic implications.
Journal
Reference
Authors
Tummers B, Burg SH
Title
High-risk human papillomavirus targets crossroads in immune signaling.
Journal
Reference
Authors
Lehoux M, D'Abramo CM, Archambault J
Title
Molecular mechanisms of human papillomavirus-induced carcinogenesis.
Journal
Reference
Authors
Pang CL, Thierry F
Title
Human papillomavirus proteins as prospective therapeutic targets.
Journal
Reference
Authors
Yugawa T, Kiyono T
Title
Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
Journal
Reference
Authors
Narisawa-Saito M, Kiyono T
Title
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.
Journal
Reference
Authors
Wolf JK, Ramirez PT.
Title
The molecular biology of cervical cancer.
Journal
Reference
Authors
zur Hausen H
Title
Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
Journal
Reference
Authors
Kim YT, Zhao M
Title
Aberrant cell cycle regulation in cervical carcinoma.
Journal
Reference
Authors
McCance DJ
Title
Human papillomaviruses and cell signaling.
Journal
Reference
Authors
Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T
Title
The role of human papilloma virus in the molecular biology of cervical carcinogenesis.
Journal
Kobe J Med Sci 50:9-19 (2004)
Reference
Authors
Tommasino M
Title
The human papillomavirus family and its role in carcinogenesis.
Journal
Reference
Authors
Bello JO, Nieva LO, Paredes AC, Gonzalez AM, Zavaleta LR, Lizano M
Title
Regulation of the Wnt/beta-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins.
Journal
Reference
Authors
Shah M, Anwar MA, Park S, Jafri SS, Choi S
Title
In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response.
Journal
Reference
Authors
James CD, Roberts S
Title
Viral Interactions with PDZ Domain-Containing Proteins-An Oncogenic Trait?
Journal
Reference
Authors
Ganti K, Broniarczyk J, Manoubi W, Massimi P, Mittal S, Pim D, Szalmas A, Thatte J, Thomas M, Tomaic V, Banks L
Title
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.
Journal
Reference
Authors
Subbaiah VK, Kranjec C, Thomas M, Banks L
Title
PDZ domains: the building blocks regulating tumorigenesis.
Journal
Reference
Authors
Banks L, Pim D, Thomas M
Title
Human tumour viruses and the deregulation of cell polarity in cancer.
Journal
Reference
Authors
Thomas M, Narayan N, Pim D, Tomaic V, Massimi P, Nagasaka K, Kranjec C, Gammoh N, Banks L
Title
Human papillomaviruses, cervical cancer and cell polarity.
Journal
Reference
Authors
Jayshree RS, Sreenivas A, Tessy M, Krishna S
Title
Cell intrinsic & extrinsic factors in cervical carcinogenesis.
Journal
Indian J Med Res 130:286-95 (2009)
Reference
Authors
Garnett TO, Duerksen-Hughes PJ
Title
Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.
Journal
Reference
Authors
Zhang L, Wu J, Ling MT, Zhao L, Zhao KN
Title
The role of the PI3K/Akt/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses.
Journal
Reference
Authors
Venuti A, Paolini F, Nasir L, Corteggio A, Roperto S, Campo MS, Borzacchiello G
Title
Papillomavirus E5: the smallest oncoprotein with many functions.
Journal
Reference
Authors
DiMaio D, Mattoon D
Title
Mechanisms of cell transformation by papillomavirus E5 proteins.
Journal
Reference
Authors
Ganguly N
Title
Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.
Journal
Reference
Authors
DiMaio D, Petti LM
Title
The E5 proteins.
Journal
Reference
Authors
De Marco F
Title
Oxidative stress and HPV carcinogenesis.
Journal
Reference
Authors
Wieringa HW, van der Zee AG, de Vries EG, van Vugt MA
Title
Breaking the DNA damage response to improve cervical cancer treatment.
Journal
Reference
Authors
Chung CH, Gillison ML
Title
Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.
Journal
Reference
Authors
Koromilas AE, Li S, Matlashewski G
Title
Control of interferon signaling in human papillomavirus infection.
Journal
Reference
Authors
Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE, Um SJ
Title
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis.
Journal
Reference
Authors
Sandberg A, Lindell G, Kallstrom BN, Branca RM, Danielsson KG, Dahlberg M, Larson B, Forshed J, Lehtio J
Title
Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.
Journal
Reference
Authors
Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P
Title
Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.
Journal
Reference
Authors
Lu Z, Hu X, Li Y, Zheng L, Zhou Y, Jiang H, Ning T, Basang Z, Zhang C, Ke Y
Title
Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin.
Journal
Reference
Authors
Xu M, Luo W, Elzi DJ, Grandori C, Galloway DA
Title
NFX1 interacts with mSin3A/histone deacetylase to repress hTERT transcription in keratinocytes.
Journal
Reference
Authors
Raff AB, Woodham AW, Raff LM, Skeate JG, Yan L, Da Silva DM, Schelhaas M, Kast WM
Title
The evolving field of human papillomavirus receptor research: a review of binding and entry.
Journal
Related pathway
csyr04612 Antigen processing and presentation
csyr04620 Toll-like receptor signaling pathway
KO pathway
LinkDB
All DBs